Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 4Thoracic 3Gynecologic 3Gastrointestinal 3Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Genitourinary 2Dermatologic 2CNS 2

Conditions

Glioma 1Glioblastoma 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Glucose × CNS × Clear all
NCT07091864 2026-05-07

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Mayo Clinic

Phase NA Recruiting
116 enrolled
CNS

Glioblastoma

NCT06855628 2025-10-28

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

Stanford University

Phase 2 Suspended
10 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡